User menu

A dose-escalating study of XRP6258 in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy: Preliminary results

Bibliographic reference Besse-Hammer, T. ; Machiels, Jean-Pascal ; Villanueva, C. ; Campone, M. ; Awada, A. ; et. al. A dose-escalating study of XRP6258 in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy: Preliminary results.45th Annual Meeting of the American-Society-of-Clinical-Oncology (Orlando (Fl), May 29-jun 02, 2009). In: Journal of Clinical Oncology, Vol. 27, no. 15 (2009)
Permanent URL http://hdl.handle.net/2078.1/58526